REQUEST A DEMO
Total
USD $0.00
Search more companies

Senfarma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Senfarma S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Senfarma S A S is based in Colombia. The head office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on April 12, 2013. It currently has a total number of 8 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 16.36% in 2023. A growth of 4.11% was recorded in its total assets. The net profit margin of Senfarma S A S decreased by 1.67% in 2023.

Headquarters
Cl 9 Sur 25 51 P2
Bogota D.C.; Bogota D.C; Postal Code: 0308

Contact Details: Purchase the Senfarma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Senfarma S A S report to view the information.
Outstanding Shares:
Purchase the Senfarma S A S report to view the information.
Incorporation Date:
April 12, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Senfarma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-16.36%
Total operating revenue
-16.36%
Operating profit (EBIT)
-39.12%
Net Profit (Loss) for the Period
-55.37%
Total assets
4.11%
Total equity
2.22%
Operating Profit Margin (ROS)
-1.64%
Net Profit Margin
-1.67%
Return on Equity (ROE)
-4.12%
Quick Ratio
-2.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?